[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

Status:
Completed

Trial end date:
2020-01-15

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic characteristic of KSR-001.

Phase 1

Kukje Pharma